Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 5/20 | 0.79 |
| ▸ | SLCO1B1 | Q9Y6L6 | 4/20 | 0.79 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.79 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.79 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.79 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.79 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.79 |
| ▸ | RHOC | P08134 | 1/20 | 0.79 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.79 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.79 |
| ▸ | ABCC3 | O15438 | 2/20 | 0.76 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.76 |
| ▸ | SLCO1B3 | Q9NPD5 | 2/20 | 0.76 |
| ▸ | PDE6D | O43924 | 4/20 | 0.68 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.56 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14107531 | 1.00 | HMGCR (0.79) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL15700274 | 0.94 | HMGCR (0.89) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL14434996 | 0.94 | HMGCR (0.89) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL14130942 | 0.94 | HMGCR (0.89) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL21637566 | 0.94 | HMGCR (0.89) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL13118083 | 0.94 | HMGCR (0.89) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL14605733 | 0.93 | HMGCR (0.81) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL13450913 | 0.89 | HMGCR (0.72) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| SCHEMBL13412147 | 0.89 | HMGCR (0.79) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 | |
| Atorvastatin SCHEMBL13900412 | 0.88 | HMGCR (1.00) | HMGCRSLCO1B1ABCB11HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1341785-B1 | HYDROLYSIS OF R(R*,R*)-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4- [(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID ESTERS WITH CALCIUM HYDROXIDE | TEVA PHARMA (IL) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007105049-A1 | DIBENZYL AMINE DERIVATIVES AS CETP INHIBITORS | PFIZER PRODUCTS INC. (US) | 2007-09-20 | — | — | WO | disclosed |
| EP-1180097-B1 | MUTUAL SALT OF AMLODIPINE AND ATORVASTATIN | PFIZER PROD INC (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2004004778-A1 | USE OF CETP INHIBITORS AND OPTIONALLY HMG COA REDUCTABLE INHIBITORS AND/OR ANTIHYPERTENSIVE AGENTS | PFIZER PRODUCTS INC. (US) | 2004-01-15 | — | — | WO | disclosed |